Thick placenta at 21 weeks
Reading File
Finding Sources
Finding Sources
Searching PubMed
thick placenta second trimester causes management
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
thick placenta 21 weeks causes differential diagnosis ultrasound
Reading Web Page
thick placenta causes differential diagnosis management second trimester
Finding Sources
I now have comprehensive information to provide a detailed answer. Here is the full clinical overview:
Thick Placenta at 21 Weeks (Placentomegaly)
Normal Reference
Placental thickness grows at roughly 1 mm per week of gestation after 20 weeks, measured sagittally at the level of the umbilical cord insertion. At 21 weeks, a thickness of ~21 mm is normal. The upper limit of normal is generally 40 mm at any gestational age, though some authors use the 90th percentile cutoff of >35 mm at 20-22 weeks as the threshold for placentomegaly.
For anterior placentas specifically: >33 mm is considered thick; for posterior/fundal placentas: >40 mm. Anterior placentas are naturally ~6-7 mm thinner than posterior/fundal ones.
Causes - Differential Diagnosis
A thickened placenta has fetal, maternal, and primary placental causes:
Fetal Causes
| Cause | Mechanism |
|---|---|
| Hydrops fetalis (immune) | Rh incompatibility - severe fetal anemia leads to placental edema |
| Non-immune hydrops | Cardiac failure, chromosomal anomaly, structural defect |
| Hemoglobinopathy (Hb Bart's / alpha-thalassemia) | Severe fetal anemia; placenta thickens as early as 10 weeks; mean PT 34.5 mm vs. 24.6 mm in controls at 18-21 weeks |
| Intrauterine infection (TORCH) | CMV, toxoplasmosis, rubella, syphilis, Zika virus - pathogens damage vascular remodeling, cause fibrosis and inflammation; often associated with ventriculomegaly, periventricular calcifications |
| Beckwith-Wiedemann syndrome | Overgrowth syndrome; also associated with macrosomia and omphalocele |
| Sacrococcygeal teratoma | High-output state causing placental enlargement |
| Chromosomal abnormalities | Trisomy 13, 18, 21; partial monosomy 13 |
Maternal Causes
| Cause | Mechanism |
|---|---|
| Diabetes mellitus (GDM or pregestational) | Villous edema, capillary proliferation, new vessel insertion, increased surface area as compensatory response |
| Severe maternal anemia | Compensatory placental enlargement |
| Pre-eclampsia | Abnormal trophoblast invasion; associated with heterogeneous thickening |
| Malaria | Parasite sequestration in placenta causing inflammation |
Primary Placental Causes
| Cause | Features |
|---|---|
| Chorioangioma | Vascular tumor; if large (>5 cm) may cause hydrops, polyhydramnios, fetal growth restriction |
| Chorioangiomatosis | Diffuse form |
| Placental mesenchymal dysplasia (PMD) | Rare; cystic placentomegaly on ultrasound resembling mole; associated with Beckwith-Wiedemann, IUGR, stillbirth |
| Subchorionic/retroplacental hematoma | May mimic thickening |
| Placental lakes | Normal variant but can contribute to apparent thickening |
| Placenta accreta spectrum (PAS) | Particularly in prior uterine scar; look for retroplacental myometrial thinning <1 mm |
In Twins (Monochorionic)
- Twin-to-twin transfusion syndrome (TTTS) - recipient twin's side enlarged
- Twin anemia-polycythemia sequence (TAPS)
Ultrasound Assessment
When a thick placenta is found at 21 weeks, evaluate:
- Measure correctly - sagittal plane, at umbilical cord insertion, perpendicular to placental surface
- Texture - homogeneous vs. heterogeneous; cystic areas (PMD, molar change); echogenic foci
- Fetal anatomy - look for hydrops (skin edema, ascites, pleural/pericardial effusions), cardiomegaly, structural anomalies
- Fetal growth/biometry - IUGR vs. macrosomia
- Amniotic fluid - polyhydramnios or oligohydramnios
- Doppler - umbilical artery, middle cerebral artery (MCA) for fetal anemia (elevated MCA-PSV)
- Placental location and cord insertion
- Look for signs of infection - ventriculomegaly, periventricular calcifications, cerebellar hypoplasia (TORCH screen)
Investigations to Consider
| Investigation | Indication |
|---|---|
| TORCH serology (CMV, toxoplasma, rubella, syphilis VDRL) | If infection suspected (especially with intracranial findings) |
| Zika virus PCR/serology | If travel history |
| Kleihauer-Betke / MCA-PSV Doppler | If fetal anemia/hydrops suspected |
| Blood group, antibody screen | Rule out alloimmunization |
| Maternal HbA1c / glucose screen | Rule out diabetes |
| Hemoglobin electrophoresis | If from high-risk ethnicity (Southeast Asian, Mediterranean) for thalassemia |
| Fetal karyotype / chromosomal microarray | If structural anomalies or suspected chromosomal cause |
| Fetal echocardiography | If non-immune hydrops or structural anomaly detected |
| Maternal CBC | Rule out severe anemia |
Prognosis and Management
- A thick placenta is a sonographic marker, not a diagnosis - the outcome depends entirely on the underlying cause.
- It has been associated with adverse outcomes including preterm delivery, fetal growth restriction, and stillbirth.
- If isolated (no other findings), repeat ultrasound in 4-6 weeks to assess progression, fetal growth, and MCA-PSV.
- Refer to maternal-fetal medicine if a cause is identified or suspicion is high.
Key bottom line: At 21 weeks, a placenta >35 mm (or >40 mm) warrants systematic evaluation. The most common and clinically urgent causes to exclude are fetal anemia (thalassemia, Rh disease), TORCH infection, diabetes, and chromosomal abnormalities.
Sources: GLOWM Ultrasound in Obstetrics (2024); Creasy & Resnik's Maternal-Fetal Medicine; PMC7890726 (Insights into placenta thickness as predictive marker of perinatal outcome)
This is a shared conversation. Sign in to Orris to start your own chat.